Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States.

Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen H -U.

Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84. doi: 10.1002/mpr.1359. Epub 2012 Aug 1.

2.

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.

Miyamoto S, Miyake N, Jarskog LF, Fleischhacker WW, Lieberman JA.

Mol Psychiatry. 2012 Dec;17(12):1206-27. doi: 10.1038/mp.2012.47. Epub 2012 May 15. Review.

PMID:
22584864
3.

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.

Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, Davis JM.

Lancet. 2012 Jun 2;379(9831):2063-71. doi: 10.1016/S0140-6736(12)60239-6. Epub 2012 May 3.

PMID:
22560607
4.

Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.

Cookson J, Hodgson R, Wildgust HJ.

J Psychopharmacol. 2012 May;26(5 Suppl):42-51. doi: 10.1177/0269881112442016. Epub 2012 Apr 2. Review.

PMID:
22472310
5.

Is rational antipsychotic polytherapy feasible? A selective review.

Kroken RA, Johnsen E.

Curr Psychiatry Rep. 2012 Jun;14(3):244-51. doi: 10.1007/s11920-012-0266-y. Review.

PMID:
22415638
6.

Lithium in pregnancy: the need to treat, the duty to ensure safety.

Gentile S.

Expert Opin Drug Saf. 2012 May;11(3):425-37. doi: 10.1517/14740338.2012.670419. Epub 2012 Mar 9. Review.

PMID:
22400907
7.

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses.

Leucht S, Hierl S, Kissling W, Dold M, Davis JM.

Br J Psychiatry. 2012 Feb;200(2):97-106. doi: 10.1192/bjp.bp.111.096594. Review.

8.

Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.

Glick ID, Correll CU, Altamura AC, Marder SR, Csernansky JG, Weiden PJ, Leucht S, Davis JM.

J Clin Psychiatry. 2011 Dec;72(12):1616-27. doi: 10.4088/JCP.11r06927.

PMID:
22244023
9.

Re-analysis of bipolar disorder and schizophrenia gene expression complements the Kraepelinian dichotomy.

Qian K, Di Lieto A, Corander J, Auvinen P, Greco D.

Adv Exp Med Biol. 2012;736:563-77. doi: 10.1007/978-1-4419-7210-1_33.

PMID:
22161352
10.

Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics.

Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU.

Mol Psychiatry. 2013 Jan;18(1):53-66. doi: 10.1038/mp.2011.143. Epub 2011 Nov 29. Review.

11.

New treatment guidelines for acute bipolar mania: a critical review.

Nivoli AM, Murru A, Goikolea JM, Crespo JM, Montes JM, González-Pinto A, García-Portilla P, Bobes J, Sáiz-Ruiz J, Vieta E.

J Affect Disord. 2012 Oct;140(2):125-41. doi: 10.1016/j.jad.2011.10.015. Epub 2011 Nov 17. Review.

PMID:
22100133
12.

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons.

Haddad PM, Das A, Keyhani S, Chaudhry IB.

J Psychopharmacol. 2012 May;26(5 Suppl):15-26. doi: 10.1177/0269881111424929. Epub 2011 Nov 5. Review.

PMID:
22057019
13.

Pharmacogenetics of response to antipsychotics in patients with schizophrenia.

Arranz MJ, Rivera M, Munro JC.

CNS Drugs. 2011 Nov 1;25(11):933-69. doi: 10.2165/11595380-000000000-00000. Review.

PMID:
22054119
14.

Schizophrenia guidelines across the world: a selective review and comparison.

Gaebel W, Riesbeck M, Wobrock T.

Int Rev Psychiatry. 2011 Aug;23(4):379-87. doi: 10.3109/09540261.2011.606801. Review.

PMID:
22026495
15.

A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo.

Klemp M, Tvete IF, Skomedal T, Gaasemyr J, Natvig B, Aursnes I.

J Clin Psychopharmacol. 2011 Dec;31(6):698-704. doi: 10.1097/JCP.0b013e31823657d9. Review.

PMID:
22020356
16.

A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia.

Citrome L.

Expert Opin Pharmacother. 2012 Aug;13(11):1545-73. doi: 10.1517/14656566.2011.626769. Epub 2011 Oct 17. Review.

PMID:
21999805
17.

An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder.

Kessing LV, Hellmund G, Andersen PK.

J Psychopharmacol. 2012 May;26(5):644-52. doi: 10.1177/0269881111414091. Epub 2011 Sep 24.

PMID:
21948935
18.

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.

Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, Purgato M, Spineli LM, Goodwin GM, Geddes JR.

Lancet. 2011 Oct 8;378(9799):1306-15. doi: 10.1016/S0140-6736(11)60873-8. Epub 2011 Aug 16. Review.

PMID:
21851976
19.

Time-dependent effect analysis of antipsychotic treatment in a naturalistic cohort study of patients with schizophrenia.

Kroken RA, Mellesdal LS, Wentzel-Larsen T, Jørgensen HA, Johnsen E.

Eur Psychiatry. 2012 Oct;27(7):489-95. doi: 10.1016/j.eurpsy.2011.04.002.

PMID:
21683554
20.

The place of observational studies in assessing the effectiveness of depot antipsychotics.

Haddad PM, Tiihonen J, Haukka J, Taylor M, Patel MX, Korhonen P.

Schizophr Res. 2011 Sep;131(1-3):260-1. doi: 10.1016/j.schres.2011.05.022. Epub 2011 Jun 12. No abstract available.

PMID:
21665440

Supplemental Content

Support Center